Inactive

This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institute of Health (NIH), Clinical Center (CC)... This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institute of Health (NIH), Clinical Center (CC), intends to solicit a quote and enter into firm-fixed price to purchase Space Oar Vue, with BOSTON SCIENTIFIC. SpaceOAR Vue Hydrogel is the next-generation PEG-based hydrogel spacer that offers enhanced visibility via CT scan, designed to help physicians improve contouring accuracy and consistently position patients receiving prostate cancer radiation. This acquisition is being conducted using policies unique to the acquisition of commercial items prescribed in FAR Part 12, in conjunction with the policies and procedures for the competition requirements of Part 6. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the CC, Office of Purchasing and Contracts, prior to the closing date, February 01, 2023 at 12:00 PM EST specified in this announcement, electronically to the attention of Noelle DeCenzo, Contract Specialist, Noelle.decenzo@nih.gov by the due date and time marked in this notice.